Financial Burden of Discarded Weight-based Antineoplastic Drugs to Payers and Patients in the Private Insurance Market.

JNCI Cancer Spectr · 2021 · PMC8328094 · PMID 34350376

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

nearly statistically significantno p-value reported

In addition, compared with patients with GI cancer, the discarded percentage was 4.8% (95% CI = 2.0% to 7.5%) lower for those with lung cancer; breast cancer displayed a nearly statistically significant 1.7% increase in discarded percentage.

also in 323 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.